Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Antigen processing and presentation (mmu04612)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
14927508
3
KLA  ATP  ATP+KLA
 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69
ATP .85 .69 1.26 .89 .89 1.26 .64
KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82
B2m
KLA  ATP  ATP+KLA
 AK086184 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930011D03 product:unclassifiable, full insert sequence [AK086184] KLA 5.41 5.23 3.54 2.86 3.11 2.98 2.23
ATP .65 .79 1.31 1.32 2.78 2.51 1.55
KLA/ATP 3.21 3.75 3.36 2.85 4.56 3.64 3.25
B2m
KLA  ATP  ATP+KLA
 NM_009735 beta-2 microglobulin (B2m), mRNA [NM_009735] KLA 1.92 1.77 1.98 2.10 2.20 2.41 3.15
ATP 1.09 1.14 1.09 1.49 1.28 1.57 2.41
KLA/ATP 1.85 2.01 1.83 2.69 2.23 2.78 4.45
Calr
KLA  ATP  ATP+KLA
 NM_007591 calreticulin (Calr), mRNA [NM_007591] KLA .86 .95 1.00 .68 .92 .93 1.37
ATP 1.12 1.34 .91 1.33 1.07 .97 1.46
KLA/ATP 1.09 1.02 .63 1.06 .65 .92 1.16
Canx
KLA  ATP  ATP+KLA
 NM_007597 calnexin (Canx), transcript variant 1, mRNA [NM_007597] KLA 1.00 1.01 .92 .87 .85 .86 1.04
ATP 1.00 1.13 .97 1.04 .90 .75 .81
KLA/ATP 1.02 1.10 .82 .90 .63 .55 .60
Cd4
KLA  ATP  ATP+KLA
 NM_013488 CD4 antigen (Cd4), mRNA [NM_013488] KLA .99 1.02 1.02 1.03 1.01 1.06 1.09
ATP 1.00 1.02 1.00 1.05 .96 .99 1.04
KLA/ATP 1.03 1.01 1.03 1.06 .97 .98 .98
Cd4
KLA  ATP  ATP+KLA
 X04836 gb|Mouse mRNA for T-cell surface glycoprotein CD4 (L3T4) [X04836] KLA .98 .91 .94 .96 .89 .92 1.03
ATP 1.11 1.07 1.02 .95 .90 .92 .88
KLA/ATP 1.04 1.00 1.01 .97 .90 1.02 .89
Cd74
KLA  ATP  ATP+KLA
 NM_001042605 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) (Cd74), transcript variant 1, mRNA [NM_001042605] KLA 1.55 1.72 1.80 1.45 1.77 1.60 2.05
ATP 1.24 1.54 1.11 2.35 1.58 1.16 2.23
KLA/ATP 2.13 2.19 1.12 3.06 1.61 1.61 4.15
Cd8a
KLA  ATP  ATP+KLA
 NM_001081110 CD8 antigen, alpha chain (Cd8a), mRNA [NM_001081110] KLA 1.02 1.03 1.04 1.04 1.07 1.03 1.02
ATP 1.01 .98 .99 1.03 1.01 1.00 .99
KLA/ATP 1.02 1.01 1.04 1.03 1.06 1.06 1.00
Cd8b1
KLA  ATP  ATP+KLA
 M17534 gb|Mouse T-cell membrane glycoprotein (Ly-3) mRNA, complete cds. [M17534] KLA 1.04 1.06 1.11 1.12 1.07 1.06 .95
ATP 1.00 1.07 .97 .97 .96 1.05 .98
KLA/ATP .96 1.02 1.07 1.03 1.05 .95 .97
Ciita
KLA  ATP  ATP+KLA
 NM_007575 class II transactivator (Ciita), mRNA [NM_007575] KLA 2.13 2.12 2.35 2.22 1.91 1.44 1.12
ATP 1.04 1.04 1.17 1.17 1.61 1.15 1.21
KLA/ATP 2.23 2.44 1.88 1.76 1.64 1.14 1.52
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Ctsb
KLA  ATP  ATP+KLA
 NM_007798 cathepsin B (Ctsb), mRNA [NM_007798] KLA .89 .86 .82 .80 .84 .84 .95
ATP .98 1.04 .91 .83 .85 .82 1.00
KLA/ATP .80 .87 .81 .81 .68 .68 .85
Ctsl
KLA  ATP  ATP+KLA
 NM_009984 cathepsin L (Ctsl), mRNA [NM_009984] KLA .85 .79 .72 .80 .79 .84 .75
ATP 1.02 1.01 1.16 .87 1.73 3.14 6.44
KLA/ATP .72 .80 1.12 .89 1.20 2.53 3.79
Ctss
KLA  ATP  ATP+KLA
 NM_021281 cathepsin S (Ctss), mRNA [NM_021281] KLA 1.10 1.10 1.12 1.19 1.11 1.43 2.02
ATP .98 .91 1.04 .79 .87 1.01 1.82
KLA/ATP 1.05 .97 1.18 .98 1.12 1.24 2.03
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-Bl
KLA  ATP  ATP+KLA
 NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80
ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47
KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39
H2-D1
KLA  ATP  ATP+KLA
 AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94
ATP .96 1.01 1.02 .95 1.05 1.00 .98
KLA/ATP .92 .94 .97 .97 .98 .92 1.03
H2-D1
KLA  ATP  ATP+KLA
 NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56
ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90
KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-K1
KLA  ATP  ATP+KLA
 M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99
ATP .98 .97 1.19 1.45 1.36 1.68 2.17
KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82
H2-K1
KLA  ATP  ATP+KLA
 NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17
ATP .98 .97 1.13 1.32 1.29 1.57 2.09
KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91
H2-M1
KLA  ATP  ATP+KLA
 NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04
ATP 1.01 .99 1.03 1.07 .92 1.03 .98
KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02
H2-M10.1
KLA  ATP  ATP+KLA
 NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94
ATP 1.06 1.04 .96 .95 .97 .98 .98
KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99
H2-M10.2
KLA  ATP  ATP+KLA
 NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40
ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66
KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92
H2-M10.3
KLA  ATP  ATP+KLA
 AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04
ATP .98 .96 1.00 .99 1.00 .99 1.00
KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03
H2-M10.4
KLA  ATP  ATP+KLA
 NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03
ATP 1.07 1.05 .97 1.08 .95 .97 1.02
KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04
H2-M10.5
KLA  ATP  ATP+KLA
 NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07
ATP 1.02 1.02 1.04 .90 1.03 .99 .99
KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04
H2-M10.6
KLA  ATP  ATP+KLA
 NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92
ATP 1.04 1.09 .96 .98 .94 1.07 .98
KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05
H2-M11
KLA  ATP  ATP+KLA
 NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03
ATP 1.02 .96 1.08 .98 1.04 .94 .98
KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99
H2-M3
KLA  ATP  ATP+KLA
 NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73
ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09
KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06
H2-M9
KLA  ATP  ATP+KLA
 NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03
ATP .96 1.06 .94 .96 1.05 1.06 1.00
KLA/ATP .96 1.01 1.01 .99 .97 .95 .98
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
H2-Q1
KLA  ATP  ATP+KLA
 NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00
ATP .99 .92 .93 1.01 1.01 1.04 1.00
KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04
H2-Q10
KLA  ATP  ATP+KLA
 NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18
ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69
KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93
H2-Q2
KLA  ATP  ATP+KLA
 NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47
ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88
KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43
H2-Q7
KLA  ATP  ATP+KLA
 NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76
ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00
KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48
H2-Q8
KLA  ATP  ATP+KLA
 NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27
ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26
KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43
H2-T22
KLA  ATP  ATP+KLA
 NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50
ATP 1.01 .95 .88 .92 .93 3.65 5.53
KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89
H2-T23
KLA  ATP  ATP+KLA
 NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43
ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49
KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06
H2-T24
KLA  ATP  ATP+KLA
 NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89
ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71
KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10
H2-T3
KLA  ATP  ATP+KLA
 NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00
ATP .98 1.08 1.03 1.01 .98 1.02 1.03
KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97
Hsp90aa1
KLA  ATP  ATP+KLA
 NM_010480 heat shock protein 90, alpha (cytosolic), class A member 1 (Hsp90aa1), mRNA [NM_010480] KLA .95 1.03 .90 .92 .80 .94 .99
ATP .96 .92 1.39 1.21 2.02 3.66 1.10
KLA/ATP .93 .92 1.32 1.01 1.85 2.21 1.20
Hsp90ab1
KLA  ATP  ATP+KLA
 NM_008302 heat shock protein 90kDa alpha (cytosolic), class B member 1 (Hsp90ab1), mRNA [NM_008302] KLA .93 1.02 .98 .82 .95 1.10 1.39
ATP 1.04 1.14 .92 1.32 1.19 1.02 .63
KLA/ATP 1.02 1.04 .80 1.12 .87 .86 .75
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa4
KLA  ATP  ATP+KLA
 NM_008300 heat shock protein 4 (Hspa4), mRNA [NM_008300] KLA 1.02 1.02 .89 .87 .82 .88 1.07
ATP 1.06 1.11 1.08 1.18 1.19 1.03 .90
KLA/ATP 1.04 1.05 .90 .94 .97 .94 .66
Hspa5
KLA  ATP  ATP+KLA
 NM_022310 heat shock protein 5 (Hspa5), mRNA [NM_022310] KLA 1.58 1.55 1.47 1.58 1.81 1.30 1.22
ATP 1.10 1.23 1.04 1.19 1.61 1.72 1.20
KLA/ATP 1.80 1.85 1.54 1.66 1.67 1.80 .93
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Ifi30
KLA  ATP  ATP+KLA
 NM_023065 interferon gamma inducible protein 30 (Ifi30), mRNA [NM_023065] KLA .74 .70 .75 .61 .66 .56 .66
ATP 1.07 1.22 1.05 1.66 1.87 1.56 1.42
KLA/ATP .81 .89 .68 1.20 1.33 1.37 1.22
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Kir3dl1
KLA  ATP  ATP+KLA
 NM_177749 killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (Kir3dl1), mRNA [NM_177749] KLA 1.01 1.02 .98 1.01 1.03 1.01 1.03
ATP .99 .98 1.05 1.11 .95 1.05 1.04
KLA/ATP .98 1.02 .92 1.10 1.07 .98 1.00
Klrc1
KLA  ATP  ATP+KLA
 NM_010652 killer cell lectin-like receptor subfamily C, member 1 (Klrc1), mRNA [NM_010652] KLA 1.00 .96 .99 .98 1.00 .98 1.01
ATP 1.03 .97 1.01 .93 1.10 1.03 1.04
KLA/ATP .98 .99 .93 1.08 1.13 .99 1.03
Klrc2
KLA  ATP  ATP+KLA
 AK036555 adult male bone cDNA, RIKEN full-length enriched library, clone:9830133D16 product:killer cell lectin-like receptor subfamily C, member 2, full insert sequence [AK036555] KLA .98 1.00 1.01 1.02 1.09 .95 .95
ATP 1.07 1.04 .96 1.00 1.03 1.21 1.03
KLA/ATP 1.01 1.01 1.08 1.17 1.15 1.13 1.11
Klrc2
KLA  ATP  ATP+KLA
 AK040721 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530020F15 product:killer cell lectin-like receptor subfamily C, member 2, full insert sequence. [AK040721] KLA .93 .97 1.06 .98 .98 .98 1.04
ATP 1.03 1.03 1.01 1.00 1.00 .95 .94
KLA/ATP 1.01 1.07 .99 .96 1.00 .95 .98
Klrc3
KLA  ATP  ATP+KLA
 NM_021378 killer cell lectin-like receptor subfamily C, member 3 (Klrc3), mRNA [NM_021378] KLA .94 .98 1.00 1.05 .98 .99 .97
ATP .98 1.00 .98 1.03 1.07 1.00 .99
KLA/ATP .99 1.02 .98 .99 .95 .97 .98
Klrd1
KLA  ATP  ATP+KLA
 NM_010654 killer cell lectin-like receptor, subfamily D, member 1 (Klrd1), mRNA [NM_010654] KLA .98 .99 .99 .94 .94 .93 1.03
ATP 1.13 1.28 1.48 1.94 1.59 1.04 1.00
KLA/ATP 1.00 .95 1.04 1.20 1.09 1.00 .94
LOC67670
8
KLA  ATP  ATP+KLA
 XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62
ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30
KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00
Lgmn
KLA  ATP  ATP+KLA
 NM_011175 legumain (Lgmn), mRNA [NM_011175] KLA .76 .74 .86 .57 .93 1.19 1.60
ATP 1.01 1.01 .89 .82 .71 .55 1.31
KLA/ATP .78 .78 .63 .73 .67 .84 1.45
Mm.19506
1
KLA  ATP  ATP+KLA
 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83
ATP .97 .90 .96 .77 .80 3.98 5.87
KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38
Mm.33314
8
KLA  ATP  ATP+KLA
 118129874 Unknown KLA 1.04 1.03 1.05 1.08 1.05 1.02 1.00
ATP .95 1.08 .99 .91 .96 1.03 1.07
KLA/ATP .99 1.00 1.02 .98 1.00 .98 1.10
Mm.37157
3
KLA  ATP  ATP+KLA
 71725357 Unknown KLA 3.95 4.01 3.86 4.78 4.90 6.06 3.35
ATP .95 .80 .85 .67 .95 2.20 2.28
KLA/ATP 3.51 3.57 4.17 3.63 4.29 4.76 5.62
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.43967
5
KLA  ATP  ATP+KLA
 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19
ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84
KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36
Mm.43967
5
KLA  ATP  ATP+KLA
 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43
ATP .96 .91 1.12 .90 .70 1.10 1.47
KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99
Mm.43973
7
KLA  ATP  ATP+KLA
 110624769 Unknown KLA 1.37 1.42 1.33 1.29 1.33 1.39 1.52
ATP 1.00 1.08 1.15 1.51 1.42 1.32 1.59
KLA/ATP 1.44 1.48 1.35 1.93 1.62 1.67 2.56
Mm.44165
1
KLA  ATP  ATP+KLA
 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10
ATP .91 .84 .96 .75 .78 3.91 6.03
KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63
Mm.47242
0
KLA  ATP  ATP+KLA
 118131153 Unknown KLA .76 .71 .67 .68 .52 .49 .29
ATP 1.00 .92 1.06 .93 1.34 1.26 .37
KLA/ATP .68 .66 .78 .79 1.61 1.54 .47
Nfya
KLA  ATP  ATP+KLA
 NM_001110832 nuclear transcription factor-Y alpha (Nfya), transcript variant 1, mRNA [NM_001110832] KLA .66 .63 .69 .67 .89 .92 .87
ATP 1.07 1.02 .41 .65 1.30 1.20 .84
KLA/ATP .68 .70 .36 .54 .82 1.19 .82
Nfya
KLA  ATP  ATP+KLA
 NM_010913 nuclear transcription factor-Y alpha (Nfya), transcript variant 2, mRNA [NM_010913] KLA 1.07 1.05 1.08 1.06 1.04 1.35 1.03
ATP .94 .92 .49 .66 1.31 1.93 1.49
KLA/ATP 1.00 .96 .71 .75 .92 1.62 1.55
Nfyb
KLA  ATP  ATP+KLA
 NM_010914 nuclear transcription factor-Y beta (Nfyb), mRNA [NM_010914] KLA 1.38 1.22 1.12 1.30 1.07 .91 .68
ATP 1.09 1.01 .98 .89 .96 1.16 .64
KLA/ATP 1.17 1.21 1.52 1.18 .95 .82 .77
Nfyc
KLA  ATP  ATP+KLA
 NM_008692 nuclear transcription factor-Y gamma (Nfyc), transcript variant 1, mRNA [NM_008692] KLA 1.09 1.19 1.18 1.12 1.17 1.29 1.27
ATP .98 1.10 1.10 1.45 1.36 1.65 1.29
KLA/ATP 1.15 1.17 1.07 1.40 1.20 1.87 1.49
Pdia3
KLA  ATP  ATP+KLA
 M73329 phospholipase C-alpha (PLC-alpha) mRNA, complete cds. [M73329] KLA .96 .91 .85 .76 .80 .80 1.14
ATP 1.08 1.23 1.01 1.30 .91 .97 .91
KLA/ATP 1.01 1.02 .78 .96 .60 .73 .61
Psme1
KLA  ATP  ATP+KLA
 NM_011189 proteasome (prosome, macropain) 28 subunit, alpha (Psme1), mRNA [NM_011189] KLA 2.12 2.17 2.68 2.70 2.93 3.22 3.09
ATP 1.11 1.09 1.06 1.31 1.16 1.25 1.96
KLA/ATP 2.47 2.48 2.32 2.69 2.58 2.66 3.97
Psme2
KLA  ATP  ATP+KLA
 NM_011190 proteasome (prosome, macropain) 28 subunit, beta (Psme2), transcript variant 1, mRNA [NM_011190] KLA 3.70 3.57 3.81 4.38 4.59 5.38 3.35
ATP .97 .88 .85 .75 .95 2.03 2.27
KLA/ATP 3.29 3.43 3.80 3.33 4.01 4.35 5.20
Psme3
KLA  ATP  ATP+KLA
 NM_011192 proteaseome (prosome, macropain) 28 subunit, 3 (Psme3), mRNA [NM_011192] KLA 1.10 1.16 1.13 1.05 1.05 1.04 1.18
ATP 1.02 1.14 1.07 1.36 1.16 1.35 1.12
KLA/ATP 1.14 1.31 1.14 1.33 1.09 1.13 1.16
Rfx5
KLA  ATP  ATP+KLA
 NM_017395 regulatory factor X, 5 (influences HLA class II expression) (Rfx5), mRNA [NM_017395] KLA 1.30 1.30 1.30 1.19 1.33 1.22 1.02
ATP 1.08 1.09 1.02 .98 .86 .96 .89
KLA/ATP 1.44 1.38 1.15 1.07 .86 1.07 1.06
Rfxank
KLA  ATP  ATP+KLA
 NM_011266 regulatory factor X-associated ankyrin-containing protein (Rfxank), transcript variant 1, mRNA [NM_011266] KLA .91 .87 .99 1.00 1.17 1.44 1.74
ATP 1.10 1.02 .95 1.29 .98 1.18 2.64
KLA/ATP 1.04 .94 .90 1.01 .93 1.33 3.07
Rfxap
KLA  ATP  ATP+KLA
 NM_133231 regulatory factor X-associated protein (Rfxap), mRNA [NM_133231] KLA .60 .59 .59 .59 .62 .77 .83
ATP .95 .93 .68 .64 1.01 1.02 .96
KLA/ATP .61 .57 .52 .55 .93 1.11 1.03
Tap1
KLA  ATP  ATP+KLA
 NM_013683 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) (Tap1), mRNA [NM_013683] KLA 7.60 7.62 9.05 9.01 9.36 8.57 4.96
ATP 1.00 1.07 .96 1.13 .74 2.83 2.43
KLA/ATP 7.99 8.80 8.37 9.52 7.44 8.61 9.95
Tap2
KLA  ATP  ATP+KLA
 NM_011530 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (Tap2), mRNA [NM_011530] KLA 4.36 4.80 4.71 5.53 4.94 5.09 2.85
ATP .93 1.12 .97 1.20 1.38 2.30 2.20
KLA/ATP 4.15 5.22 6.03 6.07 5.60 5.42 6.52
Tapbp
KLA  ATP  ATP+KLA
 NM_001025313 TAP binding protein (Tapbp), transcript variant 1, mRNA [NM_001025313] KLA 2.54 2.67 2.82 2.67 2.99 3.31 3.48
ATP 1.08 1.05 .93 .94 1.07 1.88 2.94
KLA/ATP 2.73 2.78 2.26 2.59 2.69 3.36 5.43
Tapbp
KLA  ATP  ATP+KLA
 NM_009318 TAP binding protein (Tapbp), transcript variant 2, mRNA [NM_009318] KLA 2.75 2.69 3.26 2.71 3.26 3.46 3.41
ATP 1.01 1.23 1.06 1.62 1.31 2.01 2.87
KLA/ATP 2.88 3.09 2.57 4.24 2.72 3.93 6.19
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07